
FHND5071 (1H) is a селективный ингибитор targeting the RET (rearrangement during transfection) tyrosine киназы. FHND5071 (1H) is promising for research of RET-driven cancers (such as thyroid cancer, lung cancer, etc.).
FHND5071 (1H) is a selective inhibitor targeting the RET (rearrangement during transfection) tyrosine kinase. FHND5071 (1H) is promising for research of RET-driven cancers (such as thyroid cancer, lung cancer, etc.).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.